Saol Therapeutics hit with CRL for rare genetic disease
The U.S. FDA issued a complete response letter (CRL) for the NDA to privately held Saol Therapeutics Inc.’s…
Emphysema During Lung Cancer Screening Predicts All-Cause Mortality up to 25 Years Later
Claudia I. Henschke, PhD, MD Credit: Mount Sinai Baseline emphysema at low-dose chest CT (LDCT was predictive of…